West Pharmaceutical Services (WST)
NYSEHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-04
$408.78+0.44%
Close 2026-11-04 · 1-day change
NYSEHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-04
QuarterlyIQ Insights · WST
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 45.7% |
| Our one-year growth estimate | diamond | 5.6% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 40.1 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 10 industry peers · Company calendar date is not available
WST — M&A activity — Termination of a Material Definitive Agreement
Dated 2026-10-26
Termination of a Material Definitive Agreement. 2019 Credit Agreement On October 26, 2026 (the “Effective Date”), West Pharmaceutical Services, Inc., a Pennsylvania corporation (the “Company”), (i) used a portion of the proceeds from borrowings under the New Credit Agreement (as defined and described in
Why it matters: West entered a new credit agreement on October 26 and used part of its proceeds to repay old debt. Its terms will show the cost of the change.
Watch forA filing shows the new agreement's interest cost and key limits are no worse than the old agreement's disclosed terms.
Also watch forA filing shows higher borrowing costs, tighter limits, or a material rise in debt.
Why it matters: West Vantage sales fell 7.3% in Q3, while its prior-year quarter had higher sales. A return to growth would ease this weak spot.
Watch forWest Vantage sales rise year over year in the next reported quarter.
Also watch forWest Vantage sales fall at least 5% year over year again.
Why it matters: HVP Components drove the latest sales gains. Another strong quarter would support the growth trend.
Supportive ifHVP Components sales grow at least 15% year over year in the next reported quarter.
Worry ifHVP Components sales grow less than 10% year over year or decline.
Why it matters: West cut its spending range from $250 million–$275 million. Spending above the new range would reverse that cut.
Watch forFull-year 2026 capital spending is $220 million or less.
Also watch forCapital spending for 2026 tops $220 million.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$86 on $10,000 · ±0.9% | How much price usually moves either way. |
| Bad day | $288 loss on $10,000 · 2.9% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $1,937 loss on $10,000 · 19.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.